Team: Commercialized.Bio

School Affiliation: Harvard Business School; Illinois Gies; INSEAD; London Business School; MIT Sloan; Stanford; Berkeley Haas

Description:

Commercialized.Bio is an AI-powered platform that accelerates the commercialization of biomedical and healthcare innovations by identifying high-potential patents and research findings for startup creation.

Problem:

Groundbreaking biomedical and healthcare research often remains trapped in academia due to commercialization bottlenecks, lack of entrepreneurial guidance, and inefficiencies in connecting innovators with investors and industry partners.

Solution:

Commercialized.Bio leverages AI to analyze patents, research papers, and emerging biotech trends, identifying the most promising innovations for commercialization. The platform connects researchers with entrepreneurs, investors, and industry leaders to transform cutting-edge research into viable startups.

Market:

The global biotech and healthcare innovation market is growing rapidly, with venture capital investment in biotech startups exceeding $50 billion annually. Commercialized.Bio targets researchers, universities, tech transfer offices, venture capital firms, and startup incubators and accelerators seeking to capitalize on untapped biomedical innovations.

Competition:

Current commercialization pathways rely on university tech transfer offices and consulting firms, which are slow and inefficient. AI-driven platforms like Commercialized.Bio significantly outperform traditional methods by automating patent analysis, identifying high-impact opportunities, and fostering direct connections between researchers and startup ecosystems.

Value Creation:

Commercialized.Bio accelerates the transition of biomedical research from academia to market, reducing commercialization time, increasing startup success rates, and unlocking significant economic and societal value by bringing transformative healthcare innovations to the public faster.

The Team:

Hadia Alabed, Chief Scientific Officer (CEO/CSO): Hadia Alabed graduated with a PharmD degree from the University of Trakya (Turkey), and now she is pursuing a master of science degree in Biotechnology Innovation at the Technical University of Istanbul (Turkey).
Anaïs Daoud, Chief Innovation Officer (CINO): Anaïs Daoud graduated as an Artificial Intelligence engineer from the National School of Artificial Intelligence in Algeria, and currently she is pursuing a master of science degree in AI and Machine Learning at the Technical University of Istanbul (Turkey).
Chakib Hamada, Chief Technology Officer (CTO): Chakib Hamada graduated as an Artificial Intelligence engineer from the National School of Artificial Intelligence in Algeria, and currently she is pursuing a master of science degree in AI and Machine Learning at the Technical University of Istanbul

© Copyright 2025 Poets & Quants. All rights reserved. This article may not be republished, rewritten or otherwise distributed without written permission. To reprint or license this article or any content from Poets & Quants, please submit your request HERE.